Sept 18 (Reuters) - Atlassian (TEAM.O), opens new tab said on Thursday it has agreed to acquire developer intelligence platform DX for about $1 billion in cash and restricted stock, aiming to improve ...
Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could have a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback